{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:55:56Z","timestamp":1790229356755,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/nrclinonc.2016.37","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T09:51:38Z","timestamp":1459417898000},"page":"537-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Evaluation and management of pancreatic lesions in patients with von Hippel\u2013Lindau disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Xavier M.","family":"Keutgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jonasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"BFnrclinonc201637_CR1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser, R. R.  et al. von Hippel-Lindau disease. Lancet 361, 2059\u20132067 (2003).","journal-title":"Lancet"},{"key":"BFnrclinonc201637_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher, E. R.  et al. von Hippel-Lindau disease: a genetic study. J. Med. Genet. 28, 443\u2013447 (1991).","journal-title":"J. Med. Genet."},{"key":"BFnrclinonc201637_CR3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif, F.  et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317\u20131320 (1993).","journal-title":"Science"},{"key":"BFnrclinonc201637_CR4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","volume":"332","author":"BR Seizinger","year":"1988","unstructured":"Seizinger, B. R.  et al. von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332, 268\u2013269 (1988).","journal-title":"Nature"},{"key":"BFnrclinonc201637_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"C Stolle","year":"1998","unstructured":"Stolle, C.  et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat. 12, 417\u2013423 (1998).","journal-title":"Hum. Mutat."},{"key":"BFnrclinonc201637_CR6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock, I. R.  et al. A genetic register for von Hippel-Lindau disease. J. Med. Genet. 33, 120\u2013127 (1996).","journal-title":"J. Med. Genet."},{"key":"BFnrclinonc201637_CR7","first-page":"B4763","volume":"60","author":"ML Binderup","year":"2013","unstructured":"Binderup, M. L.  et al. von Hippel-Lindau disease (vHL) \u2014 National clinical guideline for diagnosis and surveillance in Denmark. Dan. Med. J. 60, B4763 (2013).","journal-title":"Dan. Med. J."},{"key":"BFnrclinonc201637_CR8","first-page":"273","volume":"44","author":"P Decq","year":"1998","unstructured":"Decq, P. Guidelines for the maintenance of Hippel-Lindau disease in daily practice. French Society of Neurosurgery [French]. Neurochirurgie 44, 273\u2013274 (1998).","journal-title":"Neurochirurgie"},{"key":"BFnrclinonc201637_CR9","first-page":"505","volume":"144","author":"FJ Hes","year":"2000","unstructured":"Hes, F. J. & van der Luijt, R. B. Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group. Ned. Tijdschr. Geneeskd. 144, 505\u2013509 (in Dutch) (2000).","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"BFnrclinonc201637_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","volume":"68","author":"JM Lamiell","year":"1989","unstructured":"Lamiell, J. M., Salazar, F. G. & Hsia, Y. E. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68, 1\u201329 (1989).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrclinonc201637_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/133.2.289","volume":"133","author":"WL Fill","year":"1979","unstructured":"Fill, W. L., Lamiell, J. M. & Polk, N. O. The radiographic manifestations of von Hippel-Lindau disease. Radiology 133, 289\u2013295 (1979).","journal-title":"Radiology"},{"key":"BFnrclinonc201637_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0899-7071(95)00066-6","volume":"21","author":"TP Chambers","year":"1997","unstructured":"Chambers, T. P., Fishman, E. K. & Hruban, R. H. Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease. Clin. Imaging 21, 40\u201342 (1997).","journal-title":"Clin. Imaging"},{"key":"BFnrclinonc201637_CR13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","volume":"119","author":"PR Hammel","year":"2000","unstructured":"Hammel, P. R.  et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 119, 1087\u20131095 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrclinonc201637_CR14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2214\/ajr.162.5.8165988","volume":"162","author":"DM Hough","year":"1994","unstructured":"Hough, D. M., Stephens, D. H., Johnson, C. D. & Binkovitz, L. A. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. AJR Am. J. Roentgenol. 162, 1091\u20131094 (1994).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrclinonc201637_CR15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","volume":"142","author":"JA Blansfield","year":"2007","unstructured":"Blansfield, J. A.  et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 142, 814\u2013818; discussion 818. e1\u2013e2 (2007).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-013-0794-1","volume":"49","author":"H Igarashi","year":"2014","unstructured":"Igarashi, H.  et al. Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey. J. Gastroenterol. 49, 511\u2013516 (2014).","journal-title":"J. Gastroenterol."},{"key":"BFnrclinonc201637_CR17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s11605-012-1847-0","volume":"16","author":"M Charlesworth","year":"2012","unstructured":"Charlesworth, M.  et al. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J. Gastrointest. Surg. 16, 1422\u20131428 (2012).","journal-title":"J. Gastrointest. Surg."},{"key":"BFnrclinonc201637_CR18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0016-5085(91)90026-H","volume":"101","author":"HP Neumann","year":"1991","unstructured":"Neumann, H. P.  et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology 101, 465\u2013471 (1991).","journal-title":"Gastroenterology"},{"key":"BFnrclinonc201637_CR19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1976.03630070017007","volume":"136","author":"WA Horton","year":"1976","unstructured":"Horton, W. A., Wong, V. & Eldridge, R. von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch. Intern. Med. 136, 769\u2013777 (1976).","journal-title":"Arch. Intern. Med."},{"key":"BFnrclinonc201637_CR20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/msy.2000.110239","volume":"128","author":"SK Libutti","year":"2000","unstructured":"Libutti, S. K.  et al. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Surgery 128, 1022\u20131027; discussion 1027\u20131028 (2000).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jamcollsurg.2013.10.025","volume":"218","author":"AB Weisbrod","year":"2014","unstructured":"Weisbrod, A. B.  et al. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. J. Am. Coll. Surg. 218, 163\u2013169 (2014).","journal-title":"J. Am. Coll. Surg."},{"key":"BFnrclinonc201637_CR22","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1245\/s10434-012-2276-8","volume":"19","author":"AB Weisbrod","year":"2012","unstructured":"Weisbrod, A. B.  et al. Association of type O blood with pancreatic neuroendocrine tumors in von Hippel-Lindau syndrome. Ann. Surg. Oncol. 19, 2054\u20132059 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"BFnrclinonc201637_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/msy.1998.91823","volume":"124","author":"SK Libutti","year":"1998","unstructured":"Libutti, S. K.  et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 124, 1153\u20131159 (1998).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/RCT.0b013e3181b52b84","volume":"34","author":"C Neuzillet","year":"2010","unstructured":"Neuzillet, C.  et al. Difficult diagnosis of atypical cystic pancreatic lesions in von Hippel-Lindau disease. J. Comput. Assist. Tomogr. 34, 140\u2013145 (2010).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"BFnrclinonc201637_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.surg.2014.03.026","volume":"156","author":"YX Koh","year":"2014","unstructured":"Koh, Y. X., Chok, A. Y., Zheng, H. L., Tan, C. S. & Goh, B. K. A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms. Surgery 156, 83\u201396.e2 (2014).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2169\/internalmedicine.51.7194","volume":"51","author":"N Kobayashi","year":"2012","unstructured":"Kobayashi, N.  et al. Imaging findings of pancreatic cystic lesions in von Hippel-Lindau disease. Intern. Med. 51, 1301\u20131307 (2012).","journal-title":"Intern. Med."},{"key":"BFnrclinonc201637_CR27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.mpa.0000240604.26312.e4","volume":"33","author":"I Yamasaki","year":"2006","unstructured":"Yamasaki, I.  et al. Clinical characteristics of pancreatic neuroendocrine tumors in Japanese patients with von Hippel-Lindau disease. Pancreas 33, 382\u2013385 (2006).","journal-title":"Pancreas"},{"key":"BFnrclinonc201637_CR28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1677\/ERC-10-0037","volume":"17","author":"Z Erlic","year":"2010","unstructured":"Erlic, Z.  et al. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr. Relat. Cancer 17, 875\u2013883 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrclinonc201637_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","volume":"262","author":"L de Mestier","year":"2014","unstructured":"de Mestier, L.  et al. Long-term prognosis of resected pancreatic neuroendocrine tumors in von Hippel-Lindau disease is favorable and not influenced by small tumors left in place. Ann. Surg. 262, 384\u2013388 (2014).","journal-title":"Ann. Surg."},{"key":"BFnrclinonc201637_CR30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.2253011297","volume":"225","author":"HB Marcos","year":"2002","unstructured":"Marcos, H. B.  et al. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology 225, 751\u2013758 (2002).","journal-title":"Radiology"},{"key":"BFnrclinonc201637_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2046-2530-2-3","volume":"2","author":"SJ van Asselt","year":"2013","unstructured":"van Asselt, S. J.  et al. Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia 2, 3 (2013).","journal-title":"Cilia"},{"key":"BFnrclinonc201637_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1157\/13114367","volume":"27","author":"A Benitez Velazco","year":"2008","unstructured":"Benitez Velazco, A., Pacheco Capote, C. & Latre Romero, J. M. Ectopic Cushing's syndrome caused by a functioning pancreatic neuroendocrine tumour in a patient with von Hippel-Lindau disease. Rev. Esp. Med. Nucl. 27, 29\u201333 (in Spanish) (2008).","journal-title":"Rev. Esp. Med. Nucl."},{"key":"BFnrclinonc201637_CR33","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","volume":"17","author":"IM Modlin","year":"2010","unstructured":"Modlin, I. M.  et al. Chromogranin A \u2014 biological function and clinical utility in neuro endocrine tumor disease. Ann. Surg. Oncol. 17, 2427\u20132443 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"BFnrclinonc201637_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2010.02.011","volume":"165","author":"GM Portela-Gomes","year":"2010","unstructured":"Portela-Gomes, G. M., Grimelius, L., Wilander, E. & Stridsberg, M. Granins and granin-related peptides in neuroendocrine tumours. Regul. Pept. 165, 12\u201320 (2010).","journal-title":"Regul. Pept."},{"key":"BFnrclinonc201637_CR35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(90)90526-J","volume":"88","author":"RJ Hsiao","year":"1990","unstructured":"Hsiao, R. J., Neumann, H. P., Parmer, R. J., Barbosa, J. A. & O'Connor, D. T. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. Am. J. Med. 88, 607\u2013613 (1990).","journal-title":"Am. J. Med."},{"key":"BFnrclinonc201637_CR36","doi-asserted-by":"crossref","first-page":"E1731","DOI":"10.1210\/jc.2012-1548","volume":"97","author":"HH Mosli","year":"2012","unstructured":"Mosli, H. H., Dennis, A., Kocha, W., Asher, L. J. & Van Uum, S. H. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. J. Clin. Endocrinol. Metab. 97, E1731\u2013E1735 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrclinonc201637_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.beem.2004.11.013","volume":"19","author":"TC Noone","year":"2005","unstructured":"Noone, T. C., Hosey, J., Firat, Z. & Semelka, R. C. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract. Res. Clin. Endocrinol. Metab. 19, 195\u2013211 (2005).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrclinonc201637_CR38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejso.2007.07.209","volume":"34","author":"HL O'Grady","year":"2008","unstructured":"O'Grady, H. L. & Conlon, K. C. Pancreatic neuroendocrine tumours. Eur. J. Surg. Oncol. 34, 324\u2013332 (2008).","journal-title":"Eur. J. Surg. Oncol."},{"key":"BFnrclinonc201637_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2007.01.003","volume":"21","author":"AG Rockall","year":"2007","unstructured":"Rockall, A. G. & Reznek, R. H. Imaging of neuroendocrine tumours (CT\/MR\/US). Best Pract. Res. Clin. Endocrinol. Metab. 21, 43\u201368 (2007).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrclinonc201637_CR40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","volume":"37","author":"K Oberg","year":"2010","unstructured":"Oberg, K. Pancreatic endocrine tumors. Semin. Oncol. 37, 594\u2013618 (2010).","journal-title":"Semin. Oncol."},{"key":"BFnrclinonc201637_CR41","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.3748\/wjg.v21.i34.10008","volume":"21","author":"Y Fukukura","year":"2015","unstructured":"Fukukura, Y.  et al. Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas. World J. Gastroenterol. 21, 10008\u201310017 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrclinonc201637_CR42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.surg.2011.09.048","volume":"150","author":"M Kitano","year":"2011","unstructured":"Kitano, M.  et al. Comparison of 6-18F-fluoro-l-DOPA, 18F-2-deoxy-d-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery 150, 1122\u20131128 (2011).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.surg.2012.08.010","volume":"152","author":"S Turcotte","year":"2012","unstructured":"Turcotte, S.  et al. von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. Surgery 152, 1106\u20131117 (2012).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jamcollsurg.2014.01.004","volume":"218","author":"SM Sadowski","year":"2014","unstructured":"Sadowski, S. M.  et al. Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von Hippel-Lindau-associated pancreatic lesions. J. Am. Coll. Surg. 218, 997\u20131003 (2014).","journal-title":"J. Am. Coll. Surg."},{"key":"BFnrclinonc201637_CR45","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1210\/jc.2011-2626","volume":"97","author":"AB Weisbrod","year":"2012","unstructured":"Weisbrod, A. B.  et al. Clinical utility of functional imaging with 18F-FDOPA in von Hippel-Lindau syndrome. J. Clin. Endocrinol. Metab. 97, E613\u2013E617 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrclinonc201637_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","volume":"37","author":"O Corcos","year":"2008","unstructured":"Corcos, O.  et al. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. Pancreas 37, 85\u201393 (2008).","journal-title":"Pancreas"},{"key":"BFnrclinonc201637_CR47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11307-010-0374-1","volume":"13","author":"Y Krausz","year":"2011","unstructured":"Krausz, Y.  et al. 68Ga-DOTA-NOC PET\/CT imaging of neuroendocrine tumors: comparison with 111In-DTPA-octreotide (OctreoScan\u00ae). Mol. Imaging Biol. 13, 583\u2013593 (2011).","journal-title":"Mol. Imaging Biol."},{"key":"BFnrclinonc201637_CR48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13139-012-0133-0","volume":"46","author":"JR Oh","year":"2012","unstructured":"Oh, J. R.  et al. Ga-68 somatostatin receptor PET\/CT in von Hippel-Lindau disease. Nucl. Med. Mol. Imaging 46, 129\u2013133 (2012).","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"BFnrclinonc201637_CR49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-012-9631-1","volume":"42","author":"G Treglia","year":"2012","unstructured":"Treglia, G., Castaldi, P., Rindi, G., Giordano, A. & Rufini, V. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET\/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine 42, 80\u201387 (2012).","journal-title":"Endocrine"},{"key":"BFnrclinonc201637_CR50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cncr.23637","volume":"114","author":"P Chatzipantelis","year":"2008","unstructured":"Chatzipantelis, P.  et al. Endoscopic ultrasound- guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer 114, 255\u2013262 (2008).","journal-title":"Cancer"},{"key":"BFnrclinonc201637_CR51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MOG.0b013e32830bf7fb","volume":"24","author":"KK Patel","year":"2008","unstructured":"Patel, K. K. & Kim, M. K. Neuroendocrine tumors of the pancreas: endoscopic diagnosis. Curr. Opin. Gastroenterol. 24, 638\u2013642 (2008).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnrclinonc201637_CR52","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.3748\/wjg.v16.i36.4515","volume":"16","author":"K Tamura","year":"2010","unstructured":"Tamura, K.  et al. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J. Gastroenterol. 16, 4515\u20134518 (2010).","journal-title":"World J. Gastroenterol."},{"key":"BFnrclinonc201637_CR53","first-page":"598","volume":"105","author":"RK Thompson","year":"1989","unstructured":"Thompson, R. K., Peters, J. I., Sirinek, K. R. & Levine, B. A. von Hippel-Lindau syndrome presenting as pancreatic endocrine insufficiency: a case report. Surgery 105, 598\u2013604 (1989).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR54","first-page":"329","volume":"54","author":"RS Fishman","year":"1979","unstructured":"Fishman, R. S. & Bartholomew, L. G. Severe pancreatic involvement in three generations in von Hippel-Lindau disease. Mayo Clin. Proc. 54, 329\u2013331 (1979).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrclinonc201637_CR55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jcp.2006.036954","volume":"60","author":"S Blandamura","year":"2007","unstructured":"Blandamura, S.  et al. Three cases of pancreatic serous cystadenoma and endocrine tumour. J. Clin. Pathol. 60, 278\u2013282 (2007).","journal-title":"J. Clin. Pathol."},{"key":"BFnrclinonc201637_CR56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s002689900234","volume":"21","author":"TY Cheng","year":"1997","unstructured":"Cheng, T. Y., Su, C. H., Shyr, Y. M. & Lui, W. Y. Management of pancreatic lesions in von Hippel-Lindau disease. World J. Surg. 21, 307\u2013312 (1997).","journal-title":"World J. Surg."},{"key":"BFnrclinonc201637_CR57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1385\/EP:15:2:141","volume":"15","author":"R Chetty","year":"2004","unstructured":"Chetty, R., Kennedy, M., Ezzat, S. & Asa, S. L. Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions. Endocr. Pathol. 15, 141\u2013148 (2004).","journal-title":"Endocr. Pathol."},{"key":"BFnrclinonc201637_CR58","first-page":"1866","volume":"87","author":"G Deboever","year":"1992","unstructured":"Deboever, G., Dewulf, P. & Maertens, J. Common bile duct obstruction due to pancreatic involvement in the von Hippel-Lindau syndrome. Am. J. Gastroenterol. 87, 1866\u20131868 (1992).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrclinonc201637_CR59","first-page":"428","volume":"22","author":"JA Gallego Sanchez","year":"1998","unstructured":"Gallego Sanchez, J. A.  et al. Renal carcinoma and von Hippel-Lindau disease. Actas Urol. Esp. 22, 428\u2013430 (in Spanish) (1998).","journal-title":"Actas Urol. Esp."},{"key":"BFnrclinonc201637_CR60","first-page":"30","volume":"17","author":"SK Issar","year":"1996","unstructured":"Issar, S. K., Kumar, N., Sachdeva, A. K., Jain, P. & Puri, S. K. von Hippel Lindau syndrome presenting as obstructive jaundice with involvement of pancreas in two siblings. Trop. Gastroenterol. 17, 30\u201332 (1996).","journal-title":"Trop. Gastroenterol."},{"key":"BFnrclinonc201637_CR61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004836-198212000-00011","volume":"4","author":"MH Beerman","year":"1982","unstructured":"Beerman, M. H., Fromkes, J. J., Carey, L. C. & Thomas, F. B. Pancreatic cystadenoma in Von Hippel-Lindau disease: an unusual cause of pancreatic and common bile duct obstruction. J. Clin. Gastroenterol. 4, 537\u2013540 (1982).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrclinonc201637_CR62","first-page":"790","volume":"8","author":"J Boujaoude","year":"2007","unstructured":"Boujaoude, J.  et al. A benign cause of obstructive jaundice with von Hippel-Lindau disease. A case report and review of the literature. JOP 8, 790\u2013794 (2007).","journal-title":"JOP"},{"key":"BFnrclinonc201637_CR63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","volume":"95","author":"M Pavel","year":"2012","unstructured":"Pavel, M.  et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95, 157\u2013176 (2012).","journal-title":"Neuroendocrinology"},{"key":"BFnrclinonc201637_CR64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00383-012-3104-8","volume":"28","author":"S Ide","year":"2012","unstructured":"Ide, S.  et al. Tumor enucleation with preoperative endoscopic transpapillary stenting for pediatric insulinoma. Pediatr. Surg. Int. 28, 707\u2013709 (2012).","journal-title":"Pediatr. Surg. Int."},{"key":"BFnrclinonc201637_CR65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.amjsurg.2006.11.043","volume":"194","author":"T Shimura","year":"2007","unstructured":"Shimura, T.  et al. Preoperative endoscopic pancreatic stenting for prophylaxis of pancreatic duct disruption during extirpation of a pancreatic head tumor. Am. J. Surg. 194, 553\u2013555 (2007).","journal-title":"Am. J. Surg."},{"key":"BFnrclinonc201637_CR66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000140683","volume":"25","author":"T Okamoto","year":"2008","unstructured":"Okamoto, T.  et al. Usefulness of pancreatic duct stenting prior to surgery as a guide to decide the feasibility of limited pancreatic resection. Dig. Surg. 25, 175\u2013178 (2008).","journal-title":"Dig. Surg."},{"key":"BFnrclinonc201637_CR67","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.sla.0000259993.17350.3a","volume":"246","author":"JT McPhee","year":"2007","unstructured":"McPhee, J. T.  et al. Perioperative mortality for pancreatectomy: a national perspective. Ann. Surg. 246, 246\u2013253 (2007).","journal-title":"Ann. Surg."},{"key":"BFnrclinonc201637_CR68","first-page":"616","volume":"16","author":"XM Keutgen","year":"2015","unstructured":"Keutgen, X. M., Glanville, J., Kerkar, S. & Kebebew, E. Serous cystadenoma of the pancreas causing obstructive jaundice in a patient with von Hippel-Lindau disease. J. Pancreas 16, 616\u2013618 (2015).","journal-title":"J. Pancreas"},{"key":"BFnrclinonc201637_CR69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","volume":"262","author":"L de Mestier","year":"2015","unstructured":"de Mestier, L.  et al. Long-term prognosis of resected pancreatic neuroendocrine tumors in von Hippel-Lindau disease is favorable and not influenced by small tumors left in place. Ann. Surg. 262, 384\u2013388 (2015).","journal-title":"Ann. Surg."},{"key":"BFnrclinonc201637_CR70","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00268-012-1598-9","volume":"36","author":"SM Inchauste","year":"2012","unstructured":"Inchauste, S. M.  et al. Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors. World J. Surg. 36, 1517\u20131526 (2012).","journal-title":"World J. Surg."},{"key":"BFnrclinonc201637_CR71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1995","unstructured":"Choyke, P. L.  et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194, 629\u2013642 (1995).","journal-title":"Radiology"},{"key":"BFnrclinonc201637_CR72","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","volume":"112","author":"I Kayani","year":"2008","unstructured":"Kayani, I.  et al. Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112, 2447\u20132455 (2008).","journal-title":"Cancer"},{"key":"BFnrclinonc201637_CR73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000225949","volume":"90","author":"G Akerstrom","year":"2009","unstructured":"Akerstrom, G.  et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. Neuroendocrinology 90, 203\u2013208 (2009).","journal-title":"Neuroendocrinology"},{"key":"BFnrclinonc201637_CR74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","volume":"39","author":"MH Kulke","year":"2010","unstructured":"Kulke, M. H.  et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39, 735\u2013752 (2010).","journal-title":"Pancreas"},{"key":"BFnrclinonc201637_CR75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11864-011-0172-2","volume":"13","author":"WR Burns","year":"2012","unstructured":"Burns, W. R. & Edil, B. H. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr. Treat. Options Oncol. 13, 24\u201334 (2012).","journal-title":"Curr. Treat. Options Oncol."},{"key":"BFnrclinonc201637_CR76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin, M. E.  et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N. Engl. J. Med. 371, 224\u2013233 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc201637_CR77","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jhbp.257","volume":"22","author":"T Okusaka","year":"2015","unstructured":"Okusaka, T.  et al. Cytotoxic chemotherapy for pancreatic neuroendocrine tumors. J. Hepatobiliary Pancreat. Sci. 22, 628\u2013633 (2015).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrclinonc201637_CR78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11523-012-0224-y","volume":"7","author":"K Weatherstone","year":"2012","unstructured":"Weatherstone, K. & Meyer, T. Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Target Oncol. 7, 161\u2013168 (2012).","journal-title":"Target Oncol."},{"key":"BFnrclinonc201637_CR79","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jhbp.228","volume":"22","author":"M Ikeda","year":"2015","unstructured":"Ikeda, M.  et al. Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma. J. Hepatobiliary Pancreat. Sci. 22, 623\u2013627 (2015).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrclinonc201637_CR80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond, E.  et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N. Engl. J. Med. 364, 501\u2013513 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc201637_CR81","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao, J. C.  et al. Everolimus for advanced pancreatic neuroendocrine tumors. N. Engl. J. Med. 364, 514\u2013523 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc201637_CR82","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MPA.0b013e31822a645e","volume":"41","author":"T Ali","year":"2012","unstructured":"Ali, T., Kandil, D. & Piperdi, B. Long-term disease control with sunitinib in a patient with metastatic pancreatic neuroendocrine tumor (NET) associated with von Hippel-Lindau syndrome (VHL). Pancreas 41, 492\u2013493 (2012).","journal-title":"Pancreas"},{"key":"BFnrclinonc201637_CR83","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-14-0488","volume":"172","author":"WA van der Zwan","year":"2015","unstructured":"van der Zwan, W. A.  et al. GEPNETs update: radionuclide therapy in neuroendocrine tumors. Eur. J. Endocrinol. 172, R1\u2013R8 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrclinonc201637_CR84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hpb.12225","volume":"17","author":"M Lesurtel","year":"2015","unstructured":"Lesurtel, M., Nagorney, D. M., Mazzaferro, V., Jensen, R. T. & Poston, G. J. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford) 17, 17\u201322 (2015).","journal-title":"HPB (Oxford)"},{"key":"BFnrclinonc201637_CR85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.surg.2008.08.007","volume":"145","author":"F Maire","year":"2009","unstructured":"Maire, F.  et al. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors? Surgery 145, 69\u201375 (2009).","journal-title":"Surgery"},{"key":"BFnrclinonc201637_CR86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semnuclmed.2009.11.001","volume":"40","author":"H Ahmadzadehfar","year":"2010","unstructured":"Ahmadzadehfar, H., Biersack, H. J. & Ezziddin, S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin. Nucl. Med. 40, 105\u2013121 (2010).","journal-title":"Semin. Nucl. Med."},{"key":"BFnrclinonc201637_CR87","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1530\/EJE-14-0630","volume":"172","author":"T de Baere","year":"2015","unstructured":"de Baere, T.  et al. GEP-NETS update: interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur. J. Endocrinol. 172, R151\u2013R166 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrclinonc201637_CR88","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","volume":"47","author":"V Mazzaferro","year":"2007","unstructured":"Mazzaferro, V., Pulvirenti, A. & Coppa, J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J. Hepatol. 47, 460\u2013466 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrclinonc201637_CR89","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/00007890-199712270-00017","volume":"64","author":"DA Goldfarb","year":"1997","unstructured":"Goldfarb, D. A., Neumann, H. P., Penn, I. & Novick, A. C. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 64, 1726\u20131729 (1997).","journal-title":"Transplantation"},{"key":"BFnrclinonc201637_CR90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-153-3-201008030-00010","volume":"153","author":"A Qaseem","year":"2010","unstructured":"Qaseem, A., Snow, V. & Owens, D. K., Shekelle, P. & Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann. Intern. Med. 153, 194\u2013199 (2010).","journal-title":"Ann. Intern. Med."},{"key":"BFnrclinonc201637_CR91","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","volume":"10","author":"SC Clifford","year":"2001","unstructured":"Clifford, S. C.  et al. Contrasting effects on HIF-1\u03b1 regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum. Mol. Genet. 10, 1029\u20131038 (2001).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2016.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2016.37","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2016.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:30:58Z","timestamp":1684467058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2016.37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFnrclinonc201637"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2016.37","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]},"assertion":[{"value":"31 March 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}